Drug factory · FDA FEI 3011428822
Eurofins PHAST Development GmbH & Co. KG
Byk-Gulden-Str. 2, Konstanz, Germany
No problems found at FDA's last inspection, Oct 15, 2024.
No Action Indicated: inspectors found no objectionable conditions.
3 drug inspections on record since 2015: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Paliperidone | Tests it | Janssen Pharmaceuticals, Inc. | 50458-611, 50458-612 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Oct 15, 2024 | No problems found | Drug Quality Assurance | — |
| Oct 27, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 17, 2015 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.